157 related articles for article (PubMed ID: 11763177)
1. Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.
Gilger BC; Wilkie DA; Davidson MG; Allen JB
Am J Vet Res; 2001 Dec; 62(12):1892-6. PubMed ID: 11763177
[TBL] [Abstract][Full Text] [Related]
2. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.
Gilger BC; Malok E; Stewart T; Horohov D; Ashton P; Smith T; Jaffe GJ; Allen JB
Vet Immunol Immunopathol; 2000 Oct; 76(3-4):239-55. PubMed ID: 11044557
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis.
Gilger BC; Wilkie DA; Clode AB; McMullen RJ; Utter ME; Komaromy AM; Brooks DE; Salmon JH
Vet Ophthalmol; 2010 Sep; 13(5):294-300. PubMed ID: 20840106
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P
Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results.
Fischer BM; McMullen RJ; Reese S; Brehm W
BMC Vet Res; 2019 Jan; 15(1):29. PubMed ID: 30651102
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A.
Gilger BC; Malok E; Stewart T; Ashton P; Smith T; Jaffe GJ; Allen JB
Vet Ophthalmol; 2000; 3(2-3):105-110. PubMed ID: 11397291
[TBL] [Abstract][Full Text] [Related]
7. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
Gilger BC; Salmon JH; Wilkie DA; Cruysberg LP; Kim J; Hayat M; Kim H; Kim S; Yuan P; Lee SS; Harrington SM; Murray PR; Edelhauser HF; Csaky KG; Robinson MR
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2596-605. PubMed ID: 16723476
[TBL] [Abstract][Full Text] [Related]
8. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
[TBL] [Abstract][Full Text] [Related]
10. Use of Intravitreal Injection of Gentamicin in 71 Horses With Equine Recurrent Uveitis.
Launois T; González Hilarión LM; Barbe F; Leurquin C; Bihin B; Hontoir F; Dugdale A; Vandeweerd JM
J Equine Vet Sci; 2019 Jun; 77():93-97. PubMed ID: 31133325
[TBL] [Abstract][Full Text] [Related]
11. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
[TBL] [Abstract][Full Text] [Related]
13. Leptospiral antibody prevalence and surgical treatment outcome in horses with Equine Recurrent Uveitis (ERU) in Switzerland.
Voelter K; Vial Z; Pot SA; Spiess BM
Vet Ophthalmol; 2020 Jul; 23(4):648-658. PubMed ID: 32352624
[TBL] [Abstract][Full Text] [Related]
14. [Intravitreal injection of low-dose gentamicin for the treatment of ERU-affected horses].
Kleinpeter A; Göpfert A; Köhler E; Brehm W
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2019 Feb; 47(1):25-34. PubMed ID: 30808028
[TBL] [Abstract][Full Text] [Related]
15. Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.
Gilger BC; Stoppini R; Wilkie DA; Clode AB; Pinto NH; Hempstead J; Gerding J; Salmon JH
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():23-30. PubMed ID: 23910236
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.
Gratzek AT; Kaswan RL; Martin CL; Champagne ES; White SL
Equine Vet J; 1995 Sep; 27(5):327-33. PubMed ID: 8654346
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a delivery system providing long-term release of cyclosporine.
Pearson PA; Jaffe GJ; Martin DF; Cordahi GJ; Grossniklaus H; Schmeisser ET; Ashton P
Arch Ophthalmol; 1996 Mar; 114(3):311-7. PubMed ID: 8600892
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
He Y; Wang JC; Liu YL; Ma ZZ; Zhu XA; Zhang Q
J Ocul Pharmacol Ther; 2006 Apr; 22(2):121-31. PubMed ID: 16722798
[TBL] [Abstract][Full Text] [Related]
19. Serum and vitreous humor antibody titers in and isolation of Leptospira interrogans from horses with recurrent uveitis.
Wollanke B; Rohrbach BW; Gerhards H
J Am Vet Med Assoc; 2001 Sep; 219(6):795-800. PubMed ID: 11561656
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of suprachoroidal triamcinolone injection in horses with poorly responsive equine recurrent uveitis.
Gagnon NA; Hartley C; Gilger BC
Vet Ophthalmol; 2021 May; 24(3):308-312. PubMed ID: 33788369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
